Calamos Advisors LLC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 205 filers reported holding CARDLYTICS INC in Q4 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.9%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q2 2021$1,516,000
-67.5%
11,947
-71.9%
0.01%
-72.0%
Q1 2021$4,662,000
-48.7%
42,494
-33.2%
0.02%
-52.8%
Q4 2020$9,089,000
+136.3%
63,661
+16.8%
0.05%
+112.0%
Q3 2020$3,847,000
+2.7%
54,517
+1.9%
0.02%
-3.8%
Q2 2020$3,745,000
+207.7%
53,505
+53.7%
0.03%
+160.0%
Q1 2020$1,217,000
-64.2%
34,821
-35.7%
0.01%
-41.2%
Q4 2019$3,403,00054,1350.02%
Other shareholders
CARDLYTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
CAS Investment Partners, LLC 2,821,710$177,373,00029.17%
Antipodean Advisors LLC 656,000$41,236,00023.59%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 272,900$17,154,00012.97%
Oakcliff Capital Partners, LP 281,064$17,668,00010.54%
Polaris Venture Management Co. V, L.L.C. 200,000$12,572,0009.14%
Covey Capital Advisors, LLC 82,947$5,214,0005.63%
683 Capital Management, LLC 575,000$36,145,0004.13%
JS Capital Management LLC 455,000$28,601,0003.30%
CROSSLINK CAPITAL INC 152,086$9,560,0002.17%
Pier Capital, LLC 125,692$7,901,0001.29%
View complete list of CARDLYTICS INC shareholders